カテゴリー： Market Monitor Global, 世界, 医療/バイオ

受容体チロシンプロテインキナーゼERBB 3の世界市場見通し2023年-2029年

◆英語タイトル：Receptor Tyrosine Protein Kinase ERBB 3 Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8626 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：118 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Receptor Tyrosine Protein Kinase ERBB 3 Market 調査レポートは次の情報を含め、グローバルにおけるの受容体チロシンプロテインキナーゼERBB 3市場規模と予測を収録しています。・世界の受容体チロシンプロテインキナーゼERBB 3市場：売上、2018年-2023年、2024年-2029年
・世界の受容体チロシンプロテインキナーゼERBB 3市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の受容体チロシンプロテインキナーゼERBB 3市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「BA-0702」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

受容体チロシンプロテインキナーゼERBB 3のグローバル主要企業は、AstraZeneca Plc、 AVEO Pharmaceuticals, Inc.、 Etubics Corporation、 F. Hoffmann-La Roche Ltd.、 GamaMabs Pharma S.A.、 GlaxoSmithKline Plc、 Hanmi Pharmaceuticals, Co. Ltd.、 ImmunoGen, Inc.、 Kolltan Pharmaceuticals, Inc.、 Merrimack Pharmaceuticals, Inc.、 Merus B.V.、 Novartis AG、 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.、 Sihuan Pharmaceutical Holdings Group Ltd.、 Sorrento Therapeutics, Inc.、 Symphogen A/S、 Takis S.r.l.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、受容体チロシンプロテインキナーゼERBB 3のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の受容体チロシンプロテインキナーゼERBB 3市場：タイプ別、2018年-2023年、2024年-2029年
世界の受容体チロシンプロテインキナーゼERBB 3市場：タイプ別市場シェア、2022年
・BA-0702、CDX-3379、エルゲムツマブ、ETBX-031、その他

世界の受容体チロシンプロテインキナーゼERBB 3市場：用途別、2018年-2023年、2024年-2029年
世界の受容体チロシンプロテインキナーゼERBB 3市場：用途別市場シェア、2022年
・非小細胞癌、固形腫瘍、黒色腫、結腸直腸癌、その他

世界の受容体チロシンプロテインキナーゼERBB 3市場：地域・国別、2018年-2023年、2024年-2029年
世界の受容体チロシンプロテインキナーゼERBB 3市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における受容体チロシンプロテインキナーゼERBB 3のグローバル売上、2018年-2023年
・主要企業における受容体チロシンプロテインキナーゼERBB 3のグローバル売上シェア、2022年
・主要企業における受容体チロシンプロテインキナーゼERBB 3のグローバル販売量、2018年-2023年
・主要企業における受容体チロシンプロテインキナーゼERBB 3のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
AstraZeneca Plc、 AVEO Pharmaceuticals, Inc.、 Etubics Corporation、 F. Hoffmann-La Roche Ltd.、 GamaMabs Pharma S.A.、 GlaxoSmithKline Plc、 Hanmi Pharmaceuticals, Co. Ltd.、 ImmunoGen, Inc.、 Kolltan Pharmaceuticals, Inc.、 Merrimack Pharmaceuticals, Inc.、 Merus B.V.、 Novartis AG、 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.、 Sihuan Pharmaceutical Holdings Group Ltd.、 Sorrento Therapeutics, Inc.、 Symphogen A/S、 Takis S.r.l.

*************************************************************

・調査・分析レポートの概要
受容体チロシンプロテインキナーゼERBB 3市場の定義
市場セグメント
世界の受容体チロシンプロテインキナーゼERBB 3市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の受容体チロシンプロテインキナーゼERBB 3市場規模
世界の受容体チロシンプロテインキナーゼERBB 3市場規模：2022年 VS 2029年
世界の受容体チロシンプロテインキナーゼERBB 3市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの受容体チロシンプロテインキナーゼERBB 3の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の受容体チロシンプロテインキナーゼERBB 3製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：BA-0702、CDX-3379、エルゲムツマブ、ETBX-031、その他
受容体チロシンプロテインキナーゼERBB 3のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：非小細胞癌、固形腫瘍、黒色腫、結腸直腸癌、その他
受容体チロシンプロテインキナーゼERBB 3の用途別グローバル売上・予測

・地域別市場分析
地域別受容体チロシンプロテインキナーゼERBB 3市場規模 2022年と2029年
地域別受容体チロシンプロテインキナーゼERBB 3売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
AstraZeneca Plc、 AVEO Pharmaceuticals, Inc.、 Etubics Corporation、 F. Hoffmann-La Roche Ltd.、 GamaMabs Pharma S.A.、 GlaxoSmithKline Plc、 Hanmi Pharmaceuticals, Co. Ltd.、 ImmunoGen, Inc.、 Kolltan Pharmaceuticals, Inc.、 Merrimack Pharmaceuticals, Inc.、 Merus B.V.、 Novartis AG、 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.、 Sihuan Pharmaceutical Holdings Group Ltd.、 Sorrento Therapeutics, Inc.、 Symphogen A/S、 Takis S.r.l.
...

This report aims to provide a comprehensive presentation of the global market for Receptor Tyrosine Protein Kinase ERBB 3, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Receptor Tyrosine Protein Kinase ERBB 3. This report contains market size and forecasts of Receptor Tyrosine Protein Kinase ERBB 3 in global, including the following market information:
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Receptor Tyrosine Protein Kinase ERBB 3 companies in 2022 (%)
The global Receptor Tyrosine Protein Kinase ERBB 3 market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
BA-0702 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Receptor Tyrosine Protein Kinase ERBB 3 include AstraZeneca Plc, AVEO Pharmaceuticals, Inc., Etubics Corporation, F. Hoffmann-La Roche Ltd., GamaMabs Pharma S.A., GlaxoSmithKline Plc, Hanmi Pharmaceuticals, Co. Ltd., ImmunoGen, Inc. and Kolltan Pharmaceuticals, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Receptor Tyrosine Protein Kinase ERBB 3 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Receptor Tyrosine Protein Kinase ERBB 3 Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Segment Percentages, by Type, 2022 (%)
BA-0702
CDX-3379
Elgemtumab
ETBX-031
Others
Global Receptor Tyrosine Protein Kinase ERBB 3 Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Segment Percentages, by Application, 2022 (%)
Non-Small Cell Carcinoma
Solid Tumor
Melanoma
Colorectal Cancer
Others
Global Receptor Tyrosine Protein Kinase ERBB 3 Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Receptor Tyrosine Protein Kinase ERBB 3 revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Receptor Tyrosine Protein Kinase ERBB 3 revenues share in global market, 2022 (%)
Key companies Receptor Tyrosine Protein Kinase ERBB 3 sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Receptor Tyrosine Protein Kinase ERBB 3 sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Etubics Corporation
F. Hoffmann-La Roche Ltd.
GamaMabs Pharma S.A.
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
ImmunoGen, Inc.
Kolltan Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Novartis AG
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Sorrento Therapeutics, Inc.
Symphogen A/S
Takis S.r.l.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Receptor Tyrosine Protein Kinase ERBB 3, market overview.
Chapter 2: Global Receptor Tyrosine Protein Kinase ERBB 3 market size in revenue and volume.
Chapter 3: Detailed analysis of Receptor Tyrosine Protein Kinase ERBB 3 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Receptor Tyrosine Protein Kinase ERBB 3 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Receptor Tyrosine Protein Kinase ERBB 3 capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Receptor Tyrosine Protein Kinase ERBB 3 Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Receptor Tyrosine Protein Kinase ERBB 3 Overall Market Size
2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size: 2022 VS 2029
2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales: 2018-2029
3 Company Landscape
3.1 Top Receptor Tyrosine Protein Kinase ERBB 3 Players in Global Market
3.2 Top Global Receptor Tyrosine Protein Kinase ERBB 3 Companies Ranked by Revenue
3.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Companies
3.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Companies
3.5 Global Receptor Tyrosine Protein Kinase ERBB 3 Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Receptor Tyrosine Protein Kinase ERBB 3 Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Product Type
3.8 Tier 1, Tier 2 and Tier 3 Receptor Tyrosine Protein Kinase ERBB 3 Players in Global Market
3.8.1 List of Global Tier 1 Receptor Tyrosine Protein Kinase ERBB 3 Companies
3.8.2 List of Global Tier 2 and Tier 3 Receptor Tyrosine Protein Kinase ERBB 3 Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Markets, 2022 & 2029
4.1.2 BA-0702
4.1.3 CDX-3379
4.1.4 Elgemtumab
4.1.5 ETBX-031
4.1.6 Others
4.2 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue & Forecasts
4.2.1 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2023
4.2.2 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2024-2029
4.2.3 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2018-2029
4.3 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales & Forecasts
4.3.1 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2023
4.3.2 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2024-2029
4.3.3 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2018-2029
4.4 By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2022 & 2029
5.1.2 Non-Small Cell Carcinoma
5.1.3 Solid Tumor
5.1.4 Melanoma
5.1.5 Colorectal Cancer
5.1.6 Others
5.2 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue & Forecasts
5.2.1 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2023
5.2.2 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2024-2029
5.2.3 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2018-2029
5.3 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales & Forecasts
5.3.1 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2023
5.3.2 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2024-2029
5.3.3 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2018-2029
5.4 By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2022 & 2029
6.2 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue & Forecasts
6.2.1 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2023
6.2.2 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2024-2029
6.2.3 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2018-2029
6.3 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales & Forecasts
6.3.1 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2023
6.3.2 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2024-2029
6.3.3 By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2029
6.4.2 By Country – North America Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2029
6.4.3 US Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.4.4 Canada Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.4.5 Mexico Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2029
6.5.2 By Country – Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2029
6.5.3 Germany Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.5.4 France Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.5.5 U.K. Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.5.6 Italy Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.5.7 Russia Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.5.8 Nordic Countries Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.5.9 Benelux Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2029
6.6.2 By Region – Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2029
6.6.3 China Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.6.4 Japan Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.6.5 South Korea Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.6.6 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.6.7 India Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2029
6.7.2 By Country – South America Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2029
6.7.3 Brazil Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.7.4 Argentina Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales, 2018-2029
6.8.3 Turkey Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.8.4 Israel Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.8.5 Saudi Arabia Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
6.8.6 UAE Receptor Tyrosine Protein Kinase ERBB 3 Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AstraZeneca Plc
7.1.1 AstraZeneca Plc Company Summary
7.1.2 AstraZeneca Plc Business Overview
7.1.3 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.1.4 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Plc Key News & Latest Developments
7.2 AVEO Pharmaceuticals, Inc.
7.2.1 AVEO Pharmaceuticals, Inc. Company Summary
7.2.2 AVEO Pharmaceuticals, Inc. Business Overview
7.2.3 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.2.4 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.2.5 AVEO Pharmaceuticals, Inc. Key News & Latest Developments
7.3 Etubics Corporation
7.3.1 Etubics Corporation Company Summary
7.3.2 Etubics Corporation Business Overview
7.3.3 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.3.4 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.3.5 Etubics Corporation Key News & Latest Developments
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 F. Hoffmann-La Roche Ltd. Company Summary
7.4.2 F. Hoffmann-La Roche Ltd. Business Overview
7.4.3 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.4.4 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.4.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.5 GamaMabs Pharma S.A.
7.5.1 GamaMabs Pharma S.A. Company Summary
7.5.2 GamaMabs Pharma S.A. Business Overview
7.5.3 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.5.4 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.5.5 GamaMabs Pharma S.A. Key News & Latest Developments
7.6 GlaxoSmithKline Plc
7.6.1 GlaxoSmithKline Plc Company Summary
7.6.2 GlaxoSmithKline Plc Business Overview
7.6.3 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.6.4 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.6.5 GlaxoSmithKline Plc Key News & Latest Developments
7.7 Hanmi Pharmaceuticals, Co. Ltd.
7.7.1 Hanmi Pharmaceuticals, Co. Ltd. Company Summary
7.7.2 Hanmi Pharmaceuticals, Co. Ltd. Business Overview
7.7.3 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.7.4 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.7.5 Hanmi Pharmaceuticals, Co. Ltd. Key News & Latest Developments
7.8 ImmunoGen, Inc.
7.8.1 ImmunoGen, Inc. Company Summary
7.8.2 ImmunoGen, Inc. Business Overview
7.8.3 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.8.4 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.8.5 ImmunoGen, Inc. Key News & Latest Developments
7.9 Kolltan Pharmaceuticals, Inc.
7.9.1 Kolltan Pharmaceuticals, Inc. Company Summary
7.9.2 Kolltan Pharmaceuticals, Inc. Business Overview
7.9.3 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.9.4 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.9.5 Kolltan Pharmaceuticals, Inc. Key News & Latest Developments
7.10 Merrimack Pharmaceuticals, Inc.
7.10.1 Merrimack Pharmaceuticals, Inc. Company Summary
7.10.2 Merrimack Pharmaceuticals, Inc. Business Overview
7.10.3 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.10.4 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.10.5 Merrimack Pharmaceuticals, Inc. Key News & Latest Developments
7.11 Merus B.V.
7.11.1 Merus B.V. Company Summary
7.11.2 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Business Overview
7.11.3 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.11.4 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.11.5 Merus B.V. Key News & Latest Developments
7.12 Novartis AG
7.12.1 Novartis AG Company Summary
7.12.2 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Business Overview
7.12.3 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.12.4 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.12.5 Novartis AG Key News & Latest Developments
7.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
7.13.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Company Summary
7.13.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Business Overview
7.13.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.13.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.13.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Key News & Latest Developments
7.14 Sihuan Pharmaceutical Holdings Group Ltd.
7.14.1 Sihuan Pharmaceutical Holdings Group Ltd. Company Summary
7.14.2 Sihuan Pharmaceutical Holdings Group Ltd. Business Overview
7.14.3 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.14.4 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.14.5 Sihuan Pharmaceutical Holdings Group Ltd. Key News & Latest Developments
7.15 Sorrento Therapeutics, Inc.
7.15.1 Sorrento Therapeutics, Inc. Company Summary
7.15.2 Sorrento Therapeutics, Inc. Business Overview
7.15.3 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.15.4 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.15.5 Sorrento Therapeutics, Inc. Key News & Latest Developments
7.16 Symphogen A/S
7.16.1 Symphogen A/S Company Summary
7.16.2 Symphogen A/S Business Overview
7.16.3 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.16.4 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.16.5 Symphogen A/S Key News & Latest Developments
7.17 Takis S.r.l.
7.17.1 Takis S.r.l. Company Summary
7.17.2 Takis S.r.l. Business Overview
7.17.3 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Major Product Offerings
7.17.4 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue in Global (2018-2023)
7.17.5 Takis S.r.l. Key News & Latest Developments
8 Global Receptor Tyrosine Protein Kinase ERBB 3 Production Capacity, Analysis
8.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Production Capacity, 2018-2029
8.2 Receptor Tyrosine Protein Kinase ERBB 3 Production Capacity of Key Manufacturers in Global Market
8.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Receptor Tyrosine Protein Kinase ERBB 3 Supply Chain Analysis
10.1 Receptor Tyrosine Protein Kinase ERBB 3 Industry Value Chain
10.2 Receptor Tyrosine Protein Kinase ERBB 3 Upstream Market
10.3 Receptor Tyrosine Protein Kinase ERBB 3 Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Receptor Tyrosine Protein Kinase ERBB 3 Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Receptor Tyrosine Protein Kinase ERBB 3 in Global Market
Table 2. Top Receptor Tyrosine Protein Kinase ERBB 3 Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Companies, 2018-2023
Table 5. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Product Type
Table 9. List of Global Tier 1 Receptor Tyrosine Protein Kinase ERBB 3 Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Receptor Tyrosine Protein Kinase ERBB 3 Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), 2018-2023
Table 15. By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), 2024-2029
Table 16. By Application – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), 2018-2023
Table 20. By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), 2024-2029
Table 21. By Region – Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), 2018-2023
Table 25. By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), 2024-2029
Table 26. By Country - North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Receptor Tyrosine Protein Kinase ERBB 3 Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Receptor Tyrosine Protein Kinase ERBB 3 Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Receptor Tyrosine Protein Kinase ERBB 3 Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Receptor Tyrosine Protein Kinase ERBB 3 Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales, (K Pcs), 2024-2029
Table 46. AstraZeneca Plc Company Summary
Table 47. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 48. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. AstraZeneca Plc Key News & Latest Developments
Table 50. AVEO Pharmaceuticals, Inc. Company Summary
Table 51. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 52. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. AVEO Pharmaceuticals, Inc. Key News & Latest Developments
Table 54. Etubics Corporation Company Summary
Table 55. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 56. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Etubics Corporation Key News & Latest Developments
Table 58. F. Hoffmann-La Roche Ltd. Company Summary
Table 59. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 60. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 62. GamaMabs Pharma S.A. Company Summary
Table 63. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 64. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. GamaMabs Pharma S.A. Key News & Latest Developments
Table 66. GlaxoSmithKline Plc Company Summary
Table 67. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 68. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. GlaxoSmithKline Plc Key News & Latest Developments
Table 70. Hanmi Pharmaceuticals, Co. Ltd. Company Summary
Table 71. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 72. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Hanmi Pharmaceuticals, Co. Ltd. Key News & Latest Developments
Table 74. ImmunoGen, Inc. Company Summary
Table 75. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 76. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. ImmunoGen, Inc. Key News & Latest Developments
Table 78. Kolltan Pharmaceuticals, Inc. Company Summary
Table 79. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 80. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Kolltan Pharmaceuticals, Inc. Key News & Latest Developments
Table 82. Merrimack Pharmaceuticals, Inc. Company Summary
Table 83. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 84. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Merrimack Pharmaceuticals, Inc. Key News & Latest Developments
Table 86. Merus B.V. Company Summary
Table 87. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 88. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Merus B.V. Key News & Latest Developments
Table 90. Novartis AG Company Summary
Table 91. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 92. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. Novartis AG Key News & Latest Developments
Table 94. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Company Summary
Table 95. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 96. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 97. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Key News & Latest Developments
Table 98. Sihuan Pharmaceutical Holdings Group Ltd. Company Summary
Table 99. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 100. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 101. Sihuan Pharmaceutical Holdings Group Ltd. Key News & Latest Developments
Table 102. Sorrento Therapeutics, Inc. Company Summary
Table 103. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 104. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 105. Sorrento Therapeutics, Inc. Key News & Latest Developments
Table 106. Symphogen A/S Company Summary
Table 107. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 108. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 109. Symphogen A/S Key News & Latest Developments
Table 110. Takis S.r.l. Company Summary
Table 111. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Product Offerings
Table 112. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 113. Takis S.r.l. Key News & Latest Developments
Table 114. Receptor Tyrosine Protein Kinase ERBB 3 Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 115. Global Receptor Tyrosine Protein Kinase ERBB 3 Capacity Market Share of Key Manufacturers, 2021-2023
Table 116. Global Receptor Tyrosine Protein Kinase ERBB 3 Production by Region, 2018-2023 (K Pcs)
Table 117. Global Receptor Tyrosine Protein Kinase ERBB 3 Production by Region, 2024-2029 (K Pcs)
Table 118. Receptor Tyrosine Protein Kinase ERBB 3 Market Opportunities & Trends in Global Market
Table 119. Receptor Tyrosine Protein Kinase ERBB 3 Market Drivers in Global Market
Table 120. Receptor Tyrosine Protein Kinase ERBB 3 Market Restraints in Global Market
Table 121. Receptor Tyrosine Protein Kinase ERBB 3 Raw Materials
Table 122. Receptor Tyrosine Protein Kinase ERBB 3 Raw Materials Suppliers in Global Market
Table 123. Typical Receptor Tyrosine Protein Kinase ERBB 3 Downstream
Table 124. Receptor Tyrosine Protein Kinase ERBB 3 Downstream Clients in Global Market
Table 125. Receptor Tyrosine Protein Kinase ERBB 3 Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Receptor Tyrosine Protein Kinase ERBB 3 Segment by Type in 2022
Figure 2. Receptor Tyrosine Protein Kinase ERBB 3 Segment by Application in 2022
Figure 3. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, 2018-2029 (US$, Mn)
Figure 7. Receptor Tyrosine Protein Kinase ERBB 3 Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Receptor Tyrosine Protein Kinase ERBB 3 Revenue in 2022
Figure 9. By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2018-2029
Figure 11. By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2018-2029
Figure 12. By Type - Global Receptor Tyrosine Protein Kinase ERBB 3 Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2018-2029
Figure 15. By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2018-2029
Figure 16. By Application - Global Receptor Tyrosine Protein Kinase ERBB 3 Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2018-2029
Figure 20. By Region - Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2018-2029
Figure 21. By Country - North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2018-2029
Figure 22. By Country - North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2018-2029
Figure 23. US Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2018-2029
Figure 28. Germany Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 29. France Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2018-2029
Figure 37. China Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 41. India Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2018-2029
Figure 43. By Country - South America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2018-2029
Figure 44. Brazil Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share, 2018-2029
Figure 48. Turkey Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$, Mn), 2018-2029
Figure 52. Global Receptor Tyrosine Protein Kinase ERBB 3 Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Receptor Tyrosine Protein Kinase ERBB 3 by Region, 2022 VS 2029
Figure 54. Receptor Tyrosine Protein Kinase ERBB 3 Industry Value Chain
Figure 55. Marketing Channels

※参考情報

受容体チロシンプロテインキナーゼERBB3は、細胞膜に存在する受容体であり、特に細胞の成長、増殖、分化、そして生存に重要な役割を持っているタンパク質です。ERBB3は、ヒトのERBBファミリーに属しており、これは一連の受容体チロシンキナーゼの中でのサブタイプを構成します。ERBB3自体は、他のタイプのERBB受容体と協働して機能することでよく知られています。

まず、ERBB3の特徴について触れていきましょう。ERBB3には独特の構造があり、細胞外ドメイン、膜貫通ドメイン、細胞内ドメインの三つの主要な部分で構成されています。細胞外ドメインはリガンド（結合する分子）と相互作用し、膜貫通ドメインは細胞膜を貫通しています。そして、細胞内ドメインはチロシンキナーゼ活性を持たないため、単独ではシグナルを送ることはできません。この点が、他のERBBファミリーの受容体との大きな違いの一つとなっています。

ERBB3は、一般的に他のERBB受容体、特にERBB2（HER2）と協調して機能することが多いです。ERBB2はチロシンキナーゼ活性を持ち、ERBB3と結合することで、ERBB3がシグナルを発信するためのプラットフォームを提供します。これにより、細胞は様々な成長因子やシグナル分子からの情報を受け取り、適切に応答することができます。

次に、ERBB3の種類についてですが、ERBBファミリーは主に四つのメンバーから構成されます。これにはERBB1（EGFR）、ERBB2（HER2）、ERBB3（HER3）、ERBB4（HER4）が含まれます。それぞれの受容体は異なるリガンドを持ち、異なる細胞機能に関与しています。ERBB3は、特にがん研究において重要なターゲットとされているため、その機能と相互作用は詳細に研究されています。

ERBB3は、癌において特に多くの注目を集めている受容体です。いくつかのがん、特に乳がんや肺がんでは、ERBB3の発現が上昇していることが報告されています。これにより、がん細胞が異常に成長し、分裂することを助ける信号経路が活性化されます。そのため、ERBB3を標的とした治療法や薬剤が開発され、臨床試験が行われています。たとえば、ERBB3の阻害剤は癌治療の一環として利用される可能性があります。

ERBB3と関連する技術についても触れておきます。この受容体に関連する研究では、分子生物学的手法やバイオインフォマティクス技術が幅広く使用されています。例えば、遺伝子発現解析やタンパク質相互作用解析が行われ、ERBB3の機能やその調節機構についての理解が深まっています。また、特異的な抗体を用いた免疫染色やフローサイトメトリーなども利用され、ERBB3の発現量や細胞の応答を評価する際に重要な役割を果たします。

さらには、バイオマーカーとしてのERBB3の研究も進められています。ERBB3の発現パターンや活性化状況が治療効果や予後にどのように影響するかを評価するための研究が進行中です。これにより、個別化医療がさらに推進され、患者にとって最適な治療法を選択できる可能性が高まります。

ERBB3はまた、他の経路と相互作用を持つことでも知られています。たとえば、PI3K/AKT経路やMAPK経路といった重要なシグナル伝達経路と連携することが確認されています。これにより、ERBB3が細胞の運命決定にどのように寄与しているかが、より明らかになってきています。また、これらの経路の異常ががんの発生や進行に寄与するため、ERBB3は複雑な疾患メカニズムの理解においても重要な位置を占めています。

今回のように受容体チロシンプロテインキナーゼERBB3は、細胞生物学やがん研究において非常に重要な役割を果たしており、今後の研究によってその機能や関連機構のさらなる解明が期待されています。また、ERBB3をターゲットとした新たな治療法の開発が、患者の治療選択肢を広げることにつながるでしょう。したがって、ERBB3に関する研究は、基礎的な生物学のみならず、臨床応用に向けた革新にも寄与することが期待されます。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 受容体チロシンプロテインキナーゼERBB 3の世界市場見通し2023年-2029年(Receptor Tyrosine Protein Kinase ERBB 3 Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

受容体チロシンプロテインキナーゼERBB 3の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp